Literature DB >> 28961605

Radial Extracorporeal Shock Wave Therapy in an Individual With Primary Trigeminal Neuralgia: A Case Report and Literature Review.

Dai Zhang1, Ying Meng, Hong Hai, Xiao Tong Yu, Yue Wen Ma.   

Abstract

A patient with primary trigeminal neuralgia exhibited pain relief without medication after radial extracorporeal shock wave therapy. The 52-yr-old woman had a 3-yr history of primary trigeminal neuralgia, involving the right maxillary division (V2) and the mandibular division (V3). She became refractory to carbamazepine and exhibited hepatic dysfunction. She hence received 3000 to 6000 impulses of craniofacial radial extracorporeal shock wave therapy to the region centered on the surface projection of the trigeminal ganglion and pain areas at 10 Hz; the intensity ranged from 1.4 to 4.5 bars twice per week for 8 wks. At baseline, and 1, 2, and 5 mos after treatment, the Barrow Neurological Institute scores were IV, IIIa, II, and II, and the visual analog scale scores were 8, 3, 1, and 1, respectively. No complications or adverse effects were observed. The hepatic function returned to normal after the discontinuation of carbamazepine. This case report demonstrates the feasibility of radial extracorporeal shock wave therapy for primary trigeminal neuralgia without complications or adverse effects with careful regulation of the therapy intensity.

Entities:  

Mesh:

Year:  2018        PMID: 28961605     DOI: 10.1097/PHM.0000000000000831

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  3 in total

1.  Efficacy and safety of the extracorporeal shockwave therapy in patients with postherpetic neuralgia: study protocol of a randomized controlled trial.

Authors:  Lu Chen; Ruihao Zhou; Fuguo Sun; Yan Weng; Ling Ye; Pingliang Yang
Journal:  Trials       Date:  2020-07-08       Impact factor: 2.279

Review 2.  Application of extracorporeal shock wave therapy in nervous system diseases: A review.

Authors:  Juan Guo; Hong Hai; Yuewen Ma
Journal:  Front Neurol       Date:  2022-08-17       Impact factor: 4.086

3.  Effect and safety of extracorporeal shockwave therapy for postherpetic neuralgia: A randomized single-blind clinical study.

Authors:  Lu Chen; Ailing Qing; Tao Zhu; Pingliang Yang; Ling Ye
Journal:  Front Neurol       Date:  2022-09-26       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.